CO5300414A1 - Composiciones de vacunas con antigenos de streptococus de virus vsr y adyuvante estimulador de respuesta th1 - Google Patents
Composiciones de vacunas con antigenos de streptococus de virus vsr y adyuvante estimulador de respuesta th1Info
- Publication number
- CO5300414A1 CO5300414A1 CO00028930A CO00028930A CO5300414A1 CO 5300414 A1 CO5300414 A1 CO 5300414A1 CO 00028930 A CO00028930 A CO 00028930A CO 00028930 A CO00028930 A CO 00028930A CO 5300414 A1 CO5300414 A1 CO 5300414A1
- Authority
- CO
- Colombia
- Prior art keywords
- virus
- vsr
- streptococus
- antigens
- assistant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/05—Adjuvants
- C12N2501/056—Immunostimulating oligonucleotides, e.g. CpG
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Una composición de vacuna que comprende: (a) uno o más polisacáridos de Streptococcus pneumoniae conjugados con una proteína o un péptido, o no conjugados;y(b) un antígeno de VSR,junto con un adyuvante que es un estimulador preferente de una respuesta de tipo Th1.1 Un procedimiento de preparación de una composición de vacuna, que comprende mezclar un polisacárido de Streptococcus pneumoniae conjugado con la proteína D o un fragmento del mismo, con un antígeno de VSR y un excipiente farmacéuticamente aceptable.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9909077.1A GB9909077D0 (en) | 1999-04-20 | 1999-04-20 | Novel compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5300414A1 true CO5300414A1 (es) | 2003-07-31 |
Family
ID=10851924
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO00028930A CO5300414A1 (es) | 1999-04-20 | 2000-04-19 | Composiciones de vacunas con antigenos de streptococus de virus vsr y adyuvante estimulador de respuesta th1 |
Country Status (26)
Country | Link |
---|---|
US (1) | US20040228879A1 (es) |
EP (2) | EP1171159B1 (es) |
JP (1) | JP2002542204A (es) |
KR (1) | KR100632835B1 (es) |
CN (1) | CN1192797C (es) |
AR (1) | AR023535A1 (es) |
AT (1) | ATE395079T1 (es) |
AU (1) | AU754101B2 (es) |
BR (1) | BR0010682A (es) |
CA (1) | CA2365579A1 (es) |
CO (1) | CO5300414A1 (es) |
CZ (1) | CZ20013773A3 (es) |
DE (1) | DE60038877D1 (es) |
ES (1) | ES2304960T3 (es) |
GB (1) | GB9909077D0 (es) |
HK (1) | HK1045100A1 (es) |
HU (1) | HUP0201905A3 (es) |
IL (1) | IL145981A0 (es) |
MY (1) | MY125000A (es) |
NO (1) | NO20015074L (es) |
NZ (1) | NZ514961A (es) |
PL (1) | PL351894A1 (es) |
TR (1) | TR200103012T2 (es) |
TW (1) | TWI234463B (es) |
WO (1) | WO2000062801A2 (es) |
ZA (1) | ZA200108620B (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9706957D0 (en) | 1997-04-05 | 1997-05-21 | Smithkline Beecham Plc | Formulation |
GB9820525D0 (en) | 1998-09-21 | 1998-11-11 | Allergy Therapeutics Ltd | Formulation |
MY125202A (en) * | 1999-03-19 | 2006-07-31 | Smithkline Beecham Biologicals S A | Vaccine |
GB0000891D0 (en) | 2000-01-14 | 2000-03-08 | Allergy Therapeutics Ltd | Formulation |
AUPQ761200A0 (en) * | 2000-05-19 | 2000-06-15 | Hunter Immunology Limited | Compositions and methods for treatment of mucosal infections |
FR2828406B1 (fr) * | 2001-08-08 | 2005-06-24 | Aventis Pasteur | Composition vaccinale bivalente havi |
IL308456A (en) | 2005-04-08 | 2024-01-01 | Wyeth Llc | A multivalent pneumomuroral protein-polysaccharide conjugate preparation |
US9839685B2 (en) | 2006-04-13 | 2017-12-12 | The Regents Of The University Of Michigan | Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen |
TW200806315A (en) | 2006-04-26 | 2008-02-01 | Wyeth Corp | Novel formulations which stabilize and inhibit precipitation of immunogenic compositions |
US8808707B1 (en) | 2006-05-08 | 2014-08-19 | Wyeth Llc | Pneumococcal dosing regimen |
PL2271360T3 (pl) * | 2008-04-16 | 2016-03-31 | Glaxosmithkline Biologicals Sa | Szczepionka |
ES2566646T3 (es) * | 2009-06-16 | 2016-04-14 | The Regents Of The University Of Michigan | Vacunas en nanoemulsión |
SG178904A1 (en) | 2009-09-10 | 2012-04-27 | Novartis Ag | Combination vaccines against respiratory tract diseases |
CN101703769B (zh) * | 2009-11-13 | 2013-05-08 | 广东永顺生物制药股份有限公司 | 一种新型猪链球菌病四价灭活疫苗 |
AU2011262346B2 (en) * | 2010-06-04 | 2014-12-11 | Wyeth Llc | Streptococcus pneumoniae vaccine formulations |
US9107906B1 (en) | 2014-10-28 | 2015-08-18 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
RU2017120039A (ru) | 2014-12-10 | 2019-01-10 | Дженентек, Инк. | Антитела к рецепторам гематоэнцефалического барьера и способы их применения |
EP3347042A4 (en) * | 2015-09-10 | 2019-02-20 | Inventprise, LLC. | MULTIVALENT CONJUGATES WITH VIRUSUAL PARTICLES |
US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
WO2023218322A1 (en) | 2022-05-11 | 2023-11-16 | Pfizer Inc. | Process for producing of vaccine formulations with preservatives |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4235877A (en) | 1979-06-27 | 1980-11-25 | Merck & Co., Inc. | Liposome particle containing viral or bacterial antigenic subunit |
US4372945A (en) | 1979-11-13 | 1983-02-08 | Likhite Vilas V | Antigen compounds |
IL61904A (en) | 1981-01-13 | 1985-07-31 | Yeda Res & Dev | Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same |
BE889979A (fr) | 1981-08-14 | 1982-02-15 | Smith Kline Rit | Procede de preparation de polysaccharides bacteriens capsulaires antigeniques purifies, produits obtenus et leur utilisation |
US5149650A (en) | 1986-01-14 | 1992-09-22 | University Of North Carolina At Chapel Hill | Vaccines for human respiratory virus |
US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
KR0137963B1 (ko) | 1987-12-23 | 1998-04-30 | 로버트 에이. 아미테이지 | 인간의 호흡기 합포체성 바이러스에 대한 당단백질 면역 단편을 함유하는 키메라(chimeric) 당단백질 |
US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
SE466259B (sv) | 1990-05-31 | 1992-01-20 | Arne Forsgren | Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal |
PL170980B1 (pl) | 1992-06-25 | 1997-02-28 | Smithkline Beecham Biolog | Szczepionka PL PL PL PL PL PL PL |
ES2162139T5 (es) | 1993-03-23 | 2008-05-16 | Smithkline Beecham Biologicals S.A. | Composiciones de vacuna que contienen monofosforil-lipido a 3-o-desacilado. |
AU676340B2 (en) * | 1993-05-25 | 1997-03-06 | Wyeth Holdings Corporation | Adjuvants for vaccines against respiratory syncytial virus |
ATE254475T1 (de) | 1993-09-22 | 2003-12-15 | Jackson H M Found Military Med | Verfahren zur aktivierung von löslichem kohlenhydraten durch verwendung von neuen cyanylierungsreagenzien, zur herstellung von immunogenischen konstrukten |
GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
US6764682B1 (en) * | 1994-06-16 | 2004-07-20 | Aventis Pasteur Limited | Adjuvant compositions containing more than one adjuvant |
AU713040B2 (en) | 1994-07-15 | 1999-11-18 | University Of Iowa Research Foundation, The | Immunomodulatory oligonucleotides |
CA2218385A1 (en) * | 1995-04-17 | 1996-10-24 | Pierre Hauser | Induction and enhancement of the immune response to polysaccharides with bacterial lipoproteins |
GB9620795D0 (en) * | 1996-10-05 | 1996-11-20 | Smithkline Beecham Plc | Vaccines |
UA56132C2 (uk) * | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
AU1146597A (en) * | 1995-12-06 | 1997-06-27 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Compositions and method for stimulating antibody release by b lymphocytes |
SE9601158D0 (sv) * | 1996-03-26 | 1996-03-26 | Stefan Svenson | Method of producing immunogenic products and vaccines |
US6020182A (en) * | 1996-07-12 | 2000-02-01 | Connaught Laboratories Limited | Subunit respiratory syncytial virus vaccine preparation |
WO1998018819A1 (en) * | 1996-10-29 | 1998-05-07 | Smithkline Beecham Biologicals S.A. | Purification of respiratory syncytial virus antigens |
US6406705B1 (en) * | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
FR2763244B1 (fr) * | 1997-05-14 | 2003-08-01 | Pasteur Merieux Serums Vacc | Composition vaccinale multivalente a porteur mixte |
GB9712347D0 (en) * | 1997-06-14 | 1997-08-13 | Smithkline Beecham Biolog | Vaccine |
-
1999
- 1999-04-20 GB GBGB9909077.1A patent/GB9909077D0/en not_active Ceased
-
2000
- 2000-04-17 BR BR0010682-8A patent/BR0010682A/pt not_active IP Right Cessation
- 2000-04-17 IL IL14598100A patent/IL145981A0/xx unknown
- 2000-04-17 TR TR2001/03012T patent/TR200103012T2/xx unknown
- 2000-04-17 AT AT00940231T patent/ATE395079T1/de not_active IP Right Cessation
- 2000-04-17 EP EP00940231A patent/EP1171159B1/en not_active Expired - Lifetime
- 2000-04-17 WO PCT/EP2000/003514 patent/WO2000062801A2/en active Search and Examination
- 2000-04-17 DE DE60038877T patent/DE60038877D1/de not_active Expired - Lifetime
- 2000-04-17 CZ CZ20013773A patent/CZ20013773A3/cs unknown
- 2000-04-17 EP EP08151478A patent/EP1927366A1/en not_active Withdrawn
- 2000-04-17 AU AU55233/00A patent/AU754101B2/en not_active Ceased
- 2000-04-17 ES ES00940231T patent/ES2304960T3/es not_active Expired - Lifetime
- 2000-04-17 PL PL00351894A patent/PL351894A1/xx not_active Application Discontinuation
- 2000-04-17 KR KR1020017013365A patent/KR100632835B1/ko not_active IP Right Cessation
- 2000-04-17 HU HU0201905A patent/HUP0201905A3/hu not_active Application Discontinuation
- 2000-04-17 CN CNB00809053XA patent/CN1192797C/zh not_active Expired - Fee Related
- 2000-04-17 JP JP2000611937A patent/JP2002542204A/ja active Pending
- 2000-04-17 CA CA002365579A patent/CA2365579A1/en not_active Abandoned
- 2000-04-17 NZ NZ514961A patent/NZ514961A/en unknown
- 2000-04-18 MY MYPI20001649A patent/MY125000A/en unknown
- 2000-04-18 AR ARP000101808A patent/AR023535A1/es not_active Application Discontinuation
- 2000-04-19 CO CO00028930A patent/CO5300414A1/es not_active Application Discontinuation
- 2000-04-20 TW TW089107452A patent/TWI234463B/zh not_active IP Right Cessation
-
2001
- 2001-10-18 NO NO20015074A patent/NO20015074L/no not_active Application Discontinuation
- 2001-10-19 ZA ZA200108620A patent/ZA200108620B/en unknown
-
2002
- 2002-06-27 HK HK02104796.6A patent/HK1045100A1/zh unknown
-
2004
- 2004-06-15 US US10/867,880 patent/US20040228879A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE60038877D1 (de) | 2008-06-26 |
KR20010110784A (ko) | 2001-12-13 |
US20040228879A1 (en) | 2004-11-18 |
HK1045100A1 (zh) | 2002-11-15 |
AU5523300A (en) | 2000-11-02 |
EP1171159A2 (en) | 2002-01-16 |
EP1171159B1 (en) | 2008-05-14 |
JP2002542204A (ja) | 2002-12-10 |
PL351894A1 (en) | 2003-06-30 |
ES2304960T3 (es) | 2008-11-01 |
HUP0201905A2 (en) | 2002-09-28 |
IL145981A0 (en) | 2002-07-25 |
NO20015074L (no) | 2001-11-15 |
AR023535A1 (es) | 2002-09-04 |
WO2000062801A2 (en) | 2000-10-26 |
TR200103012T2 (tr) | 2002-06-21 |
AU754101B2 (en) | 2002-11-07 |
ATE395079T1 (de) | 2008-05-15 |
TWI234463B (en) | 2005-06-21 |
MY125000A (en) | 2006-07-31 |
BR0010682A (pt) | 2002-02-05 |
WO2000062801A3 (en) | 2001-01-11 |
CN1192797C (zh) | 2005-03-16 |
EP1927366A1 (en) | 2008-06-04 |
NO20015074D0 (no) | 2001-10-18 |
NZ514961A (en) | 2003-08-29 |
ZA200108620B (en) | 2002-09-13 |
CN1355710A (zh) | 2002-06-26 |
HUP0201905A3 (en) | 2003-12-29 |
CZ20013773A3 (cs) | 2002-05-15 |
KR100632835B1 (ko) | 2006-10-16 |
GB9909077D0 (en) | 1999-06-16 |
CA2365579A1 (en) | 2000-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5300414A1 (es) | Composiciones de vacunas con antigenos de streptococus de virus vsr y adyuvante estimulador de respuesta th1 | |
MY125202A (en) | Vaccine | |
DK1104306T3 (da) | Præparater af CpG- og saponinadjuvanser og fremgangsmåder til anvendelse deraf | |
WO2004041157A3 (en) | Group b streptococcus vaccine | |
EP1731166A3 (en) | Streptococcus pneumoniae proteins and vaccines | |
DK1187629T3 (da) | Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid | |
DE69519634T2 (de) | Pneumokokken-polysaccharid-rekombinante-pneumolysin-konjugate als impfstoffe für die immunisierung gegen pneumokokken-infektionen | |
TR199801722T2 (xx) | Peptit imm�nojenler. | |
PT1221968E (pt) | Processo de obtenção de respostas imunes celulares de proteínas | |
DE60329106D1 (de) | Ghrelin-träger-konjugate | |
LU91924I2 (fr) | Composition vaccinale comprenant le polysaccharidecapsulaire et Haemophilus influenzae type b coupl é à l'anatoxine tétanique, l'antigène diphtérique,l'antigène tétanique, des antigènes de la polio, des antigènes de la coqueluche et du phosphate d'aluminium | |
DK0754055T3 (da) | Gruppe A-streptokok-polysaccharid-immunogen-præparater og metoder | |
IL136125A0 (en) | Antigenic group b streptococcus type ii and type iii polysaccharide fragments having a 2, 5-anhydro-d-mannose terminal structure and conjugate vaccine thereof | |
EP0090581A3 (en) | Small peptides with the specificity of foot and mouth disease viral antigens | |
WO2002032923A3 (en) | Improved formulations using heat shock/stress protein-peptide complexes | |
WO2001081380A3 (en) | Immunogenic pneumococcal protein and vaccine compositions thereof | |
DE69637435D1 (de) | Saponin-zusammensetzungen und deren verwendung | |
CO5241277A1 (es) | Vacuna | |
DE69130953D1 (de) | Immunverstärkung von impfstoffen, besonders von impfstoffen gegen schweinepleuropneumonie | |
ATE204761T1 (de) | Pharmazeutische antigen-/antikörperpräparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |